Literature DB >> 11280462

Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T cell lymphoma.

M Sugaya1, K Nakamura, A Asahina, K Tamaki.   

Abstract

Angioimmunoblastic T cell lymphoma (AILD) is a type of peripheral T cell lymphoma associated with fever and generalized lymphadenopathy. Cutaneous manifestations are seen in approximately 40% of the patients. We report herein a Japanese male patient with AILD associated with generalized purpura. The histology of the purpura included leukocytoclastic vasculitis with IgA deposits, which is rare in this disease. Using in situ hybridization and PCR methods, we showed that the involved lymph node was positive for Epstein-Barr virus and that the purpura was negative.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280462     DOI: 10.1111/j.1346-8138.2001.tb00083.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

Review 1.  Neoplasms of follicular helper T-cells: an insight into the pathobiology.

Authors:  Surabhi Jain; Saumyaranjan Mallick; Prashant Ramteke; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-06-20

2.  Rapidly progressive glomerulonephritis in a patient with angioimmunoblastic T-cell lymphoma: a rare autopsy case showing IgA vasculitis and cylinder-like deposits.

Authors:  Hirofumi Watanabe; Fumiyoshi Fujishima; Kyoko Inokura; Rui Makino; Kensuke Daikoku; Rui Sasaki; Ryo Ichinohasama; Hiroshi Sato; Kensuke Joh; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2022-06-03       Impact factor: 2.070

3.  Angioimmunoblastic T-cell Lymphoma Associated with IgA Nephropathy.

Authors:  Yukinori Harada; Kei Sakai; Shiho Asaka; Kazutaka Nakayama
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

4.  EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.

Authors:  Ahmed E Eladl; Kazuyuki Shimada; Yuka Suzuki; Taishi Takahara; Seiichi Kato; Kei Kohno; Ahmed Ali Elsayed; Chun-Chieh Wu; Takashi Tokunaga; Tomohiro Kinoshita; Mamiko Sakata-Yanagimoto; Shigeo Nakamura; Akira Satou
Journal:  Cancer Med       Date:  2019-12-02       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.